Clinical investigation of medicinal products for prevention of stroke and systemic embolic events in patients with non-valvular atrial fibrillation

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/341363/2014
Published16/07/2014
Effective from26/12/2014
KeywordsStroke, systemic embolism, atrial fibrillation, anticoagulant
DescriptionThis document provides guidance on the coduct of trials to develop medicinal products in prevention of stroke and systemic embolic events in patients with non-valvular artial fibrillation.


Document history

Revision 1

Current version

PDF iconAdopted guideline

 

PDF iconOverview of comments

 

PDF iconSecond draft guideline

 

PDF iconDraft guideline

 

PDF iconConcept paper

In operation: 26/12/2014–present

 

Published: 11/11/2014

 

Published: 15/11/2013

 

Published: 15/08/2012

 

Published: 07/04/2011


Related content


Topics

How useful was this page?

Add your rating